HQ - Palo Alto
Summary
BridgeBio is a commercial-stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Neil Kumar
Founder and CEO
Brian Stephenson
CFO
Cameron Turtle
Senior Vice President